Percutaneous management of paravalvular leaks
Related Experiment Video
Updated: Jan 30, 2026

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
Joel P Giblett1,2, Bushra S Rana1, Leonard M Shapiro1
1Department of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Insights
Paravalvular leak (PVL) closure is a common complication after valve surgery. Percutaneous closure is now the primary treatment, offering improved outcomes and reduced complications.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Paravalvular leak (PVL) occurs in 5-17% of patients post-prosthetic valve implantation.
- While often benign, PVLs can lead to significant morbidity and mortality.
- Percutaneous closure is the current first-line treatment for PVL.
Purpose of the Study:
- To review the frequency and clinical consequences of PVL closure.
- To discuss the role of cardiac imaging in PVL assessment and management.
- To summarize clinical evidence for percutaneous PVL closure.
Main Methods:
- Review of literature on paravalvular leak (PVL) closure.
- Discussion of cardiac imaging techniques (echocardiography, CT) for PVL assessment.
- Analysis of national registries and comparative data for percutaneous vs. surgical closure.
Main Results:
- Percutaneous closure is effective and becoming the standard of care for PVL.
- Cardiac imaging plays a crucial role in guiding PVL closure procedures.
- Evidence from registries supports the efficacy of percutaneous closure compared to surgical options.
Conclusions:
- Percutaneous closure is the preferred treatment for paravalvular leaks.
- Comprehensive imaging is essential for successful PVL management.
- Clinical data support the safety and efficacy of percutaneous PVL closure.
Abstract:
Paravalvular leak (PVL) is a complication that occurs in 5-17% of patients after surgical prosthetic valve implantation. Whereas PVLs can be benign, some PVLs are associated with substantial morbidity and mortality. Percutaneous closure using occluders specifically designed to improve closure and reduce procedural complications has now become the first-line treatment for PVL. In this Review, we first detail the frequency and clinical consequences of PVL closure. The role of cardiac imaging in the assessment and management of PVL, including echocardiographic imaging and adjunctive techniques such as CT, is then discussed, together with important considerations for the percutaneous closure of PVL, such as access site and device selection. Finally, we summarize the clinical evidence for percutaneous closure of PVL, including large national registries from Ireland, Spain and the UK, as well as head-to-head data comparing this procedure with surgical closure.
Related Concept Videos
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
Managing Impressions
Management of Insomnia
Cystic Fibrosis: Management
Sinus disease and chronic...
Angina IV: Management

